Endava plc investors face a November 30, 2026, deadline to seek appointment as lead plaintiff in the securities fraud class action. Levi & Korsinsky, LLP has joined the litigation, alleging that CEO John Cotterell and CFO Mark Thurston bear personal liability for alleged misstatements regarding internal controls.

The legal action stems from a sharp share price decline after the company disclosed internal control issues and placed its CFO on administrative leave. Multiple law firms are pursuing claims that Endava failed to disclose material adverse facts about its business operations between September 4, 2025, and September 21, 2026.

Market reaction and analyst stance

The turmoil began when outside auditors raised concerns about accounting treatments, leading to an immediate loss of investor confidence. Shares fell as much as $0.68, or 24.37%, to close at $2.11 during trading hours on September 22, 2026. After-hours trading saw a further drop of 12.2% ($0.34 per share).

Deutsche Bank lowered its price target for Endava to $2 from $3, maintaining a Hold rating. Analyst Nate Svensson cited increased risk associated with the ongoing internal probe and external legal inquiries as the primary drivers for the revision.

Legal allegations and class period

The complaints assert that defendants violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. Firms including Glancy Prongay Wolke & Rotter LLP, Faruqi & Faruqi, Robbins LLP, Kehoe Law Firm, Block & Leviton LLP, Kaplan Fox & Kilsheimer LLP, Kirby McInerney LLP, Bronstein, Gewirtz & Grossman, LLC, Schall, Brown & Schwartz LLP, Bragar Eagel & Squire, P.C., Levi & Korsinsky, LLP, and the Law Offices of Frank R. Cruz allege that throughout the Class Period (September 4, 2025, to September 21, 2026), Endava failed to disclose:

• The need for additional review of accounting treatment for certain customer and supplier agreements.
• The likelihood of delaying fourth quarter and full year FY26 financial results.
• Reasons to doubt the effectiveness of internal controls and procedures.
• That positive statements about business prospects lacked a reasonable basis.

Kaplan Fox & Kilsheimer LLP notes that while investors do not need to seek appointment as lead plaintiff to remain members of the proposed class, they must act by the November 30, 2026 deadline to move for lead plaintiff status. The firm emphasizes that contacting them does not create an attorney-client relationship but encourages those with losses to discuss their options. Similarly, Faruqi & Faruqi and the Law Offices of Frank R. Cruz urge shareholders who purchased or acquired Endava common stock during the Class Period to submit claims to potentially recover losses.

Bronstein, Gewirtz & Grossman, LLC states that investors who suffered losses in Endava have until November 30, 2026, to request that the Court appoint them as lead plaintiff. The firm notes that the ability to share in any recovery does not require serving as lead plaintiff. Peretz Bronstein, Founding Partner, stated that the firm’s practice centers on restoring investor capital and ensuring corporate accountability.

Block & Leviton LLP announced on September 30, 2026, that it has filed a lawsuit against Endava. The firm states that anyone who purchased or otherwise acquired Endava securities between September 4, 2025, and September 21, 2026, and has lost money may be eligible, whether or not they have sold their investment. The firm notes that a class has not yet been certified, and until certification occurs, investors are not represented by an attorney.

Expansion of legal inquiries

Multiple law firms are now investigating Endava for potential misstatements or omissions made to investors. Kehoe Law Firm joins a crowded field including Glancy Prongay Wolke & Rotter LLP, which has already filed a formal complaint. Under the SEC Whistleblower Program, individuals with non-public information may receive rewards totaling up to 30% of any successful recovery.

Bragar Eagel & Squire, P.C. announced on October 1, 2026, that a class action lawsuit has been filed against Endava plc in the United States District Court for the Southern District of New York. The firm encourages investors who suffered losses to contact partners Brandon Walker or Melissa Fortunato to discuss their options. The complaint alleges violations of federal securities laws through false or misleading statements regarding accounting reviews, delayed financial results, and internal control effectiveness.

Block & Leviton LLP announced on September 22, 2026, that it is investigating whether Endava or its executives made misstatements regarding accounting practices. The Law Offices of Frank R. Cruz confirmed it is continuing its investigation, highlighting that the announcement of CFO Mark Thurston's administrative leave precipitated the significant intraday drop in share value. The firm notes that Thurston was placed on leave upon the recommendation of the Audit Committee pending an investigation by independent outside counsel initiated by auditor concerns.

Hagens Berman is focused on whether Endava may have to restate its historical financial statements. Schall, Brown & Schwartz LLP (SBS) is investigating claims regarding false or misleading statements, noting shares fell by nearly 24.4% following the announcement of Thurston's leave. SBS reminds shareholders who purchased shares of DAVA during the class period to contact the firm regarding possible lead plaintiff appointments. The firm states that appointment as lead plaintiff is not required to partake in any recovery. According to the complaint, Endava failed to maintain appropriate internal controls and required additional review for its accounting treatment of certain supplier agreements and customer contracts. SBS encourages affected investors to contact Brian Schall or David Schwartz to discuss their rights free of charge.

The Law Offices of Howard G. Smith announced that a class action lawsuit has been filed on behalf of investors who purchased Endava plc common stock between September 4, 2025, and September 21, 2026. The firm reminds investors of the upcoming November 30, 2026 deadline to file a lead plaintiff motion. Investors who suffered losses are urged to contact the firm via email at howardsmith@howardsmithlaw.com or by telephone at (215) 638-4847 to discuss their legal rights. The firm reiterates that membership in the class action does not require taking action at this time; investors may retain counsel of their choice or remain absent members.

Pomerantz LLP announced on September 29, 2026, that it is investigating claims on behalf of investors, noting the ADR price fell $0.68 per ADR, or 24.37%, to close at $2.11 on September 22, 2026.

Faruqi & Faruqi, LLP announced on September 29, 2026, that it is investigating potential claims against Endava and reminds investors of the November 30, 2026 deadline to seek the role of lead plaintiff. Robbins LLP informed investors that a class action was filed alleging Endava misled investors regarding its accounting treatment of certain customer and supplier agreements.

Kirby McInerney LLP stated that courts typically appoint investors with the largest financial loss as lead plaintiffs, rather than those with simply the largest investment portfolio. The firm noted that lead plaintiffs have the power to influence case strategy and settlement decisions. Investors are encouraged to contact Lauren Molinaro of Kirby McInerney LLP to discuss their rights at no cost.

Robbins LLP announced on October 1, 2026, that it has filed a class action lawsuit against Endava plc. The firm represents investors on a contingency fee basis and states that serving as lead plaintiff is not required to share in any potential recovery. Founding Partner Brian J. Robbins emphasized that companies have an obligation to provide investors with complete and accurate information so that markets can function fairly and efficiently. Investors may contact attorney Aaron Dumas Jr. at Robbins LLP for more information.

Personal liability claims

Levi & Korsinsky, LLP notified investors that CEO John Cotterell and CFO Mark Thurston face alleged personal securities liability, including Section 20(a) control person claims. The complaint charges that both officers had the power to control the contents of Endava's SEC reports, press releases, and presentations to analysts. Each allegedly received these materials before or shortly after release and could have stopped or corrected them.

The pleading asserts that neither officer disclosed that the customer and supplier agreement accounting required additional review, which allegedly meant Endava would delay its fourth quarter and full year 2026 results. Given their positions and access to non-public information, both defendants allegedly knew adverse facts were being withheld from the market. Joseph E. Levi, Esq., stated that the litigation will test whether these officers bear personal responsibility for the alleged investor losses.

Fiscal results timeline

Endava intends to publish its fiscal fourth quarter and full year 2026 financial results, and file its Annual Report on Form 20-F for fiscal 2026, by November 2, 2026. The company will announce the specific date and time of its earnings release and conference call once they have been scheduled.

Company overview

Endava is a provider of next-generation technology services operating across payments, insurance, banking and capital markets, technology, media, telecommunications, healthcare, mobility, retail and consumer goods, and other sectors. As of March 31, 2026, the company employed 11,225 people across locations in Europe, the Americas, Asia Pacific, and the Middle East.

TD Cowen analyst Bryan Bergin has maintained a Hold rating on Endava (NYSE: DAVA) while lowering the price target to $3.5 from $4. The adjustment reflects a revised outlook on the stock's valuation.

Rating and Price Target

The research note updates the investment stance on Endava without altering the Hold recommendation. The price target reduction signals a lower expected price level compared to the previous estimate.